These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pulmonary arterial hypertension and microRNAs--an ever-growing partnership. Wang Y; Xue XY; Liu YX; Wang KF; Zang XF; Wang J; Wang PL; Zhang J; Pan L; Zhang SY; Wang JX Arch Med Res; 2013 Oct; 44(7):483-7. PubMed ID: 24051036 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment. Bienertova-Vasku J; Novak J; Vasku A J Am Soc Hypertens; 2015 Mar; 9(3):221-34. PubMed ID: 25660363 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of microRNA in the lungs of rats with pulmonary arterial hypertension. Xiao T; Xie L; Huang M; Shen J Mol Med Rep; 2017 Feb; 15(2):591-596. PubMed ID: 28000863 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in pulmonary arterial hypertension. Zhou G; Chen T; Raj JU Am J Respir Cell Mol Biol; 2015 Feb; 52(2):139-51. PubMed ID: 25192340 [TBL] [Abstract][Full Text] [Related]
10. [Female gender and pulmonary arterial hypertension: a complex relationship]. Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125 [TBL] [Abstract][Full Text] [Related]
11. DNA Damage and Pulmonary Hypertension. Ranchoux B; Meloche J; Paulin R; Boucherat O; Provencher S; Bonnet S Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338373 [TBL] [Abstract][Full Text] [Related]
12. Treatment goals of pulmonary hypertension. McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644 [TBL] [Abstract][Full Text] [Related]
14. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling]. Kayikçioğlu M Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761 [TBL] [Abstract][Full Text] [Related]
15. Role of Noncoding RNA in Pulmonary Arterial Hypertension and Potential Drug Therapeutic Target. Zhang CY; Liu M; Wan JM; Gao MQ; Zhang Y; Soyan M; Wang HL; Bai Y Curr Top Med Chem; 2018; 18(12):975-986. PubMed ID: 30027849 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension. Kim JD; Lee A; Choi J; Park Y; Kang H; Chang W; Lee MS; Kim J Exp Mol Med; 2015 Jul; 47(7):e175. PubMed ID: 26228095 [TBL] [Abstract][Full Text] [Related]
17. Genomics and proteomics of pulmonary vascular disease. Geraci M; Meyrick B Compr Physiol; 2011 Jan; 1(1):467-83. PubMed ID: 23737182 [TBL] [Abstract][Full Text] [Related]
18. Recent research progress of microRNAs in hypertension pathogenesis, with a focus on the roles of miRNAs in pulmonary arterial hypertension. Miao C; Chang J; Zhang G Mol Biol Rep; 2018 Dec; 45(6):2883-2896. PubMed ID: 30298350 [TBL] [Abstract][Full Text] [Related]
19. The potential of biomarkers in pulmonary arterial hypertension. Cracowski JL; Leuchte HH Am J Cardiol; 2012 Sep; 110(6 Suppl):32S-38S. PubMed ID: 22921030 [TBL] [Abstract][Full Text] [Related]
20. Critical effects of epigenetic regulation in pulmonary arterial hypertension. Chen D; Gao W; Wang S; Ni B; Gao Y Cell Mol Life Sci; 2017 Oct; 74(20):3789-3808. PubMed ID: 28573430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]